rosiglitazone maleate
Sponsors
Dana-Farber Cancer Institute, National Institute of Allergy and Infectious Diseases (NIAID), Fox Chase Cancer Center, University of California, San Francisco, GlaxoSmithKline
Conditions
AtherosclerosisBladder CancerBrain and Central Nervous System TumorsCushing's DiseaseDiabetes Mellitus, Type 2HIV InfectionsHead and Neck CancerHyperinsulinemia
Phase 1
Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone
CompletedNCT00362726
Start: 2006-09-30End: 2006-11-30Target: 14Updated: 2011-04-08
Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate
CompletedNCT00551564
Start: 2007-07-31End: 2008-09-08Updated: 2017-08-04
Phase 2
Rosiglitazone in Treating Patients With Liposarcoma
CompletedNCT00004180
Start: 1999-10-31End: 2015-05-31Updated: 2023-06-26
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
NCT00098852
Start: 2004-10-31Target: 25Updated: 2014-01-06
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
CompletedNCT00369174
Start: 2006-06-30Updated: 2013-02-13
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
TerminatedNCT00612066
Start: 2007-04-30End: 2010-11-30Updated: 2020-08-06
Rosiglitazone in Treating Patients With Pituitary Tumors
TerminatedNCT00616642
Start: 2006-10-31End: 2010-11-30Updated: 2020-08-14
Phase 3
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
CompletedNCT00116831
Start: 2005-01-31End: 2008-08-31Updated: 2017-03-23
Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
CompletedNCT00484419
Start: 2007-05-31End: 2008-04-30Updated: 2016-10-04
Unknown Phase
Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities
CompletedNCT00015691
Target: 105Updated: 2013-07-22
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
WithdrawnNCT00084578
Start: 2004-03-31End: 2006-04-30Updated: 2013-07-15
Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
CompletedNCT00143624
Start: 2003-06-30End: 2009-12-31Target: 50Updated: 2009-12-09